Host lysozyme-mediated lysis of Lactococcus lactis facilitates delivery of colitis-attenuating superoxide dismutase to inflamed colons.
about
Antioxidant therapy for treatment of inflammatory bowel disease: Does it work?Use of Wild Type or Recombinant Lactic Acid Bacteria as an Alternative Treatment for Gastrointestinal Inflammatory Diseases: A Focus on Inflammatory Bowel Diseases and Mucositis.Current Understanding of Dysbiosis in Disease in Human and Animal Models.Impact of probiotic supplements on microbiome diversity following antibiotic treatment of mice.Secretion of biologically active pancreatitis-associated protein I (PAP) by genetically modified dairy Lactococcus lactis NZ9000 in the prevention of intestinal mucositis.Gut Microbiota, Inflammation, and Colorectal Cancer.Pannexin hemichannels: A novel promising therapy target for oxidative stress related diseases.Hypothalamic paraventricular nucleus stimulation reduces intestinal injury in rats with ulcerative colitis.Surface Proteins of Lactococcus lactis: Bacterial Resources for Muco-adhesion in the Gastrointestinal Tract.Differential Ecological Specificity of Protist and Bacterial Microbiomes across a Set of Termite Species.Whole-transcriptome analysis of oxidative stress response genes in carotenoid-producing Enterococcus gilvus.Lactococcus lactis As a Versatile Vehicle for Tolerogenic Immunotherapy.Single plasmid systems for inducible dual protein expression and for CRISPR-Cas9/CRISPRi gene regulation in lactic acid bacterium Lactococcus lactis.Synthetic Biology Approaches to Engineer Probiotics and Members of the Human Microbiota for Biomedical Applications.The influence of diet on anti-cancer immune responsiveness.Complete Genome Sequence of Lactococcus lactis subsp. lactis G50 with Immunostimulating Activity, Isolated from Napier Grass.
P2860
Q26777641-74AD276E-44B1-4AD2-A149-5EF56E64D10AQ33650357-B84198EA-A54A-4FE9-86B3-488542058764Q34521876-86D6151A-26BC-459C-9559-DEE5555DD0EDQ35952315-023C4811-4B03-4043-B78F-FAEFF432D722Q37640672-559BFF7E-8E94-4A94-9E2E-C4D4AEF72FFBQ38949434-8250D9FA-C135-4009-B721-1693C351FA29Q39179457-1882854E-8914-432D-93DE-393C748B8623Q39707159-11E2FD0A-E230-427E-B81B-C4BA43695EDAQ47094937-6259D453-7E58-42F4-A5D7-608EE856943BQ47192224-BF97F7C2-560A-4430-BB38-584E67655F4FQ47378141-AAB02F28-9960-4C9E-A73D-5D3143E625A2Q49444745-E7129192-9B74-4B86-8B36-EDD45936105EQ49646934-8DC57FE5-A558-4DCF-93FE-FB145489F6D9Q50532218-700E263D-4AD5-44B1-AE66-7B282AB08964Q53700576-B53BC2BA-41DD-42F6-A1FD-8E351305BA1AQ55279380-34E2FDD4-62BC-4D62-8F3F-F63AF6C1F157
P2860
Host lysozyme-mediated lysis of Lactococcus lactis facilitates delivery of colitis-attenuating superoxide dismutase to inflamed colons.
description
2015 nî lūn-bûn
@nan
2015年の論文
@ja
2015年論文
@yue
2015年論文
@zh-hant
2015年論文
@zh-hk
2015年論文
@zh-mo
2015年論文
@zh-tw
2015年论文
@wuu
2015年论文
@zh
2015年论文
@zh-cn
name
Host lysozyme-mediated lysis o ...... dismutase to inflamed colons.
@ast
Host lysozyme-mediated lysis o ...... dismutase to inflamed colons.
@en
type
label
Host lysozyme-mediated lysis o ...... dismutase to inflamed colons.
@ast
Host lysozyme-mediated lysis o ...... dismutase to inflamed colons.
@en
prefLabel
Host lysozyme-mediated lysis o ...... dismutase to inflamed colons.
@ast
Host lysozyme-mediated lysis o ...... dismutase to inflamed colons.
@en
P2093
P2860
P50
P356
P1476
Host lysozyme-mediated lysis o ...... dismutase to inflamed colons.
@en
P2093
Carey Ann Gallini
Chloé Béal
Gaëlle Quéré
Jason H Kim
Johan van Hylckama Vlieg
Jonathan N Glickman
Kathrin Fenn
Monia Michaud
Pascal Courtin
Patrick Veiga
P2860
P304
P356
10.1073/PNAS.1501897112
P407
P577
2015-06-08T00:00:00Z